Nobelpharma Co., Ltd.
3 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
3
Ending by 2030
Jun 2029
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jan 23, 2027The maintenance fee for Agent for regenerating tympanic membrane or external auditory canal (US 10,357,595) comes due Jan 23, 2027. Unpaid by Jul 23, 2027, it lapses early.
- 1 fee due Apr 20, 2027The maintenance fee for Agent for regenerating tympanic membrane or external auditory canal (US 9,161,904) comes due Apr 20, 2027. Unpaid by Oct 20, 2027, it lapses early.
Recent changes
- 3 of the patents on this record were granted since Aug 17, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,161,904 | Agent for regenerating tympanic membrane or external auditory canal In force · From the USPTO record | In force | From the USPTO record | |
| US 10,117,969 | Agent for regenerating tympanic membrane or external auditory canal In force · From the USPTO record | In force | From the USPTO record | |
| US 10,357,595 | Agent for regenerating tympanic membrane or external auditory canal In force · From the USPTO record | In force | From the USPTO record | |
| US 9,809,563 | Maleic acid salt of anti-prion compound, method for producing the same and pharmaceutical composition of the same In force · From the USPTO record | In force | From the USPTO record | |
| US 10,813,765 | Voice Disorder Treatment Tool and Voice Disorder Treatment Set In force · High confidence | In force | High confidence | |
| US 11,051,985 | Preparation jig for tympanic membrane regenerating agent and preparation vessel for tympanic membrane regenerating agent In force · From the USPTO record | In force | From the USPTO record | |
| US 11,523,908 | Dysphonia treatment tool In force · From the USPTO record | In force | From the USPTO record | |
| US 11,517,424 | Tool for molding dysphonia treatment tool, and method for bending front piece of dysphonia treatment tool In force · From the USPTO record | In force | From the USPTO record | |
| US 12,773,403 | Scopolamine Compositions and Transdermal Patches Made Therefrom In force · High confidence | In force | High confidence | |
| US 12,746,232 | Patch for Alleviating or Treating Symptoms of Neurodegenerative Disease In force · High confidence | In force | High confidence |
Also on record, not counted in the 11: 3 patents in force now held by others · 2 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
9 no status recorded